Literature DB >> 21229118

Intradermal Hepatitis B Vaccine: Pilot study.

D G Ruddock, A Dickson.   

Abstract

Intramuscular administration of hepatitis B (HB) vaccine is safe and efficacious, but its cost has limited its availability. In this pilot study, 49 of 56 participants who received 2 μg of intradermal (ID) HB vaccine (one tenth the intramuscular dose) at the beginning of administration, at 1 month, and at 6 months developed protective levels of antibody to HB surface antigen. Although questions remain, the cost savings of this technique make it worth considering.

Entities:  

Year:  1992        PMID： 21229118      PMCID： PMC2145616     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  12 in total

1.  Worldwide elimination of hepatitis B transmission: we have the way, we need the will.

Authors:  D P Francis; H S Margolis
Journal:  JAMA       Date:  1989-04-28       Impact factor: 56.272

2.  Intradermal hepatitis B virus vaccine: immunogenicity and side-effects in adults.

Authors:  K D Miller; R D Gibbs; M M Mulligan; T B Nutman; D P Francis
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

3.  Hypersensitivity to intradermal hepatitis B vaccine.

Authors:  P N Goldwater
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

4.  Intradermal vaccination against hepatitis B.

Authors:  W L Irving; M Alder; J B Kurtz; B Juel-Jensen
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321

5.  Two superb vaccines against hepatitis B in Mexican standoff.

Authors:  F E André
Journal:  JAMA       Date:  1988 Apr 22-29       Impact factor: 56.272

6.  Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine.

Authors:  M M Horowitz; W B Ershler; W P McKinney; R J Battiola
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

7.  Cost-benefit analysis of hepatitis B vaccination.

Authors:  B Jönsson
Journal:  Postgrad Med J       Date:  1987       Impact factor: 2.401

8.  Evaluation of a reduced dose of hepatitis B vaccine administered intradermally.

Authors:  G Zoulek; B Lorbeer; W Jilg; F Deinhardt
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

9.  Successful short course for intradermal hepatitis B vaccine.

Authors:  P N Goldwater; D G Woodfield
Journal:  N Z Med J       Date:  1984-12-26

10.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.